HDAC9 and cancer: Histone deacetylases (HDACs) deacetylate the histone lysine residues, remodel chromatin, and play an important role in gene transcription.1 Due to overexpression and aberrant activity in a variety of cancer subtypes, HDAC is considered a prospective and successful anticancer drug target, and already has been proved to be a successful target.